Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3557)
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
5,230
Price
$31.29
Total Value
$163.66K
Shares Held After
4,367
% of Holdings
54.5%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$33.20
Total Value
$67.53K
Shares Held After
231,558
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
15,000
Price
$15.33
Total Value
$229.95K
Shares Held After
198,588
% of Holdings
7.0%
Entrada Therapeutics, Inc. (TRDA)
Sethuraman Natarajan — President, Research & Develop.
Shares
25,907
Price
$15.39
Total Value
$398.81K
Shares Held After
216,317
% of Holdings
10.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.96
Total Value
$138.21K
Shares Held After
18,305
% of Holdings
30.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
47,963
Price
$0.72
Total Value
$34.53K
Shares Held After
1,679,330
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
116
Price
$234.09
Total Value
$27.15K
Shares Held After
41,786
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
105
Price
$232.57
Total Value
$24.42K
Shares Held After
41,902
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
165
Price
$231.87
Total Value
$38.26K
Shares Held After
42,007
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$229.87
Total Value
$229.87
Shares Held After
42,172
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
80
Price
$227.37
Total Value
$18.19K
Shares Held After
42,173
% of Holdings
0.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
7,144
Price
$22.99
Total Value
$164.22K
Shares Held After
32,600
% of Holdings
18.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
5,467
Price
$18.92
Total Value
$103.45K
Shares Held After
600,004
% of Holdings
0.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,795
Price
$6.01
Total Value
$34.83K
Shares Held After
271,774
% of Holdings
2.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,625
Price
$63.48
Total Value
$103.16K
Shares Held After
38,498
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
1,104
Price
$425.02
Total Value
$469.22K
Shares Held After
20,729
% of Holdings
5.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
21,097
Price
$54.04
Total Value
$1.14M
Shares Held After
65,623
% of Holdings
24.3%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
37,327
Price
$53.52
Total Value
$2.00M
Shares Held After
86,720
% of Holdings
30.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
1,431
Price
$74.45
Total Value
$106.53K
Shares Held After
11,014
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
8,680
Price
$73.35
Total Value
$636.70K
Shares Held After
12,445
% of Holdings
41.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
124
Price
$99.97
Total Value
$12.40K
Shares Held After
85,533
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
7,434
Price
$99.29
Total Value
$738.12K
Shares Held After
85,657
% of Holdings
8.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,872
Price
$98.42
Total Value
$381.08K
Shares Held After
93,091
% of Holdings
4.0%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,243
Price
$32.79
Total Value
$73.55K
Shares Held After
36,621
% of Holdings
5.8%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$203.33
Total Value
$1.22M
Shares Held After
378,682
% of Holdings
1.6%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
40,000
Price
$50.10
Total Value
$2.00M
Shares Held After
2,878,326
% of Holdings
1.4%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
143
Price
$31.00
Total Value
$4.43K
Shares Held After
66,083
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,023
Price
$30.16
Total Value
$422.99K
Shares Held After
66,226
% of Holdings
17.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
800
Price
$234.02
Total Value
$187.21K
Shares Held After
41,382
% of Holdings
1.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,420
Price
$232.92
Total Value
$330.75K
Shares Held After
42,182
% of Holdings
3.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
780
Price
$232.04
Total Value
$180.99K
Shares Held After
43,602
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
370
Price
$230.87
Total Value
$85.42K
Shares Held After
44,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
98
Price
$229.71
Total Value
$22.51K
Shares Held After
44,752
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
932
Price
$228.75
Total Value
$213.20K
Shares Held After
44,850
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
600
Price
$227.45
Total Value
$136.47K
Shares Held After
45,782
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
289
Price
$83.16
Total Value
$24.03K
Shares Held After
173,371
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$82.60
Total Value
$74.34K
Shares Held After
173,660
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
811
Price
$81.02
Total Value
$65.71K
Shares Held After
174,560
% of Holdings
0.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
58,394
Price
$0.73
Total Value
$42.63K
Shares Held After
1,727,293
% of Holdings
3.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$24.90
Total Value
$116.61K
Shares Held After
110,342
% of Holdings
4.1%
Moderna, Inc. (MRNA)
Hussain Abbas — Director
Shares
5,682
Price
$46.63
Total Value
$264.95K
Shares Held After
12,066
% of Holdings
32.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,362
Price
$571.95
Total Value
$779.00K
Shares Held After
40,513
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,197
Price
$571.22
Total Value
$1.83M
Shares Held After
41,875
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,621
Price
$570.28
Total Value
$2.06M
Shares Held After
45,072
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$569.18
Total Value
$479.82K
Shares Held After
48,693
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
197
Price
$568.37
Total Value
$111.97K
Shares Held After
49,536
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$567.17
Total Value
$45.37K
Shares Held After
49,733
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$565.78
Total Value
$113.16K
Shares Held After
49,813
% of Holdings
0.4%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$714.13
Total Value
$1.43K
Shares Held After
17,503
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$712.09
Total Value
$712.09
Shares Held After
17,505
% of Holdings
0.0%
Showing 1551–1600 of 3557 transactions (page 32 of 72)